We found that silencing ALKBH3 through siRNA transfection significantly inhibited cell growth in human NSCLC in vitro and in vivo and that, in culture, p21 and p27 were upregulated following ALKBH3 knockdown. The gene discussed is CDKN1B; the disease is non-small cell lung carcinoma.